Abstract
Infections are a growing global threat, and the number of resistant species of microbial pathogens is alarming. However, the rapid development of cross-resistant or multidrug-resistant strains and the development of so-called ‘superbugs’ are in stark contrast to the number of newly launched anti-infectives on the market. In this review, I summarize the causes of antimicrobial resistance, briefly discuss different approaches to the discovery and development of new anti-infective drugs, and focus on drug repurposing strategy, which is discussed from all possible perspectives. A comprehensive overview of drugs of other indications tested for their in vitro antimicrobial activity to support existing anti-infective therapeutics is provided, including several critical remarks on this strategy of repurposing non-antibiotics to antibacterial drugs.
【저자키워드】 Drug repurposing, Antibiotics, antimicrobial resistance, infections, Non-antibiotic drugs, 【초록키워드】 drugs, drug, in vitro, pathogen, Critical, strain, microbial, Support, indication, multidrug-resistant, approach, tested, provided, cause, anti-infective drugs, cross-resistant, 【제목키워드】 microbial, overcome,